Stella Diagnostics Inc.

SLDXOTCHealthcare● Active

$0.02

+$0.01(+60.71%)

Market Cap$2194891

P/E Ratio—

52W High$0.05195

52W Low$0.0111

Avg Volume242

Open$0.01

Beta-0.28

Earnings Financials Revenue

Stella Diagnostics Inc. (SLDX) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

SLDX · earnings · updated Jun 9, 2026

Latest Earnings

Q3 FY2023Report Date: Sep 30, 2023

EPS Actual

-$0.00

Revenue

—

Fiscal Period

Q3 FY2023

FY ends December

Report Date

Sep 30, 2023

After Market Close

SLDX reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q3 FY2023	Sep 30, 2023	—	-$0.00	—	—	—	—

Q3 FY2023

Sep 30, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for SLDX.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q3 FY2023	Sep 30, 2023	—	$0.10	$0.10	+0.00%

Q3 FY2023+0.00%

Report Date

Sep 30, 2023

EPS Beat/Miss

—

Price Before

$0.10

Price After

$0.10

Beat Rate0 / 1 quarters

Largest Move+0.00% (Q3 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Stella Diagnostics Inc. (SLDX) most recently reported earnings on September 30, 2023 for Q3 FY2023, posting EPS of $-0.00 (in line with the analyst consensus of —). The next SLDX earnings date is expected around September 1, 2026.

Each quarter, investors track SLDX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SLDX revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

SLDX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

SLDX earnings · 4 questions

Stella Diagnostics Inc.'s next earnings report is expected around September 1, 2026. SLDX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SLDX historically reports after market close (AMC).

SLDX earnings datewhen is SLDX earningsSLDX next earnings datewhen does SLDX report earningsSLDX earnings calendar

▸ Source: FMP · Stella Diagnostics Inc. SEC filings · US GAAP · Stella Diagnostics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026